Alcohol Causes Oxidatively Damaged Proteins to Build Up in Neural Cells and Tissues

Tabloski Akunne^*
*Correspondence: Tabloski Akunne, Department of Clinical Research, University of Southern Denmark, 5230 Odense, Denmark, Email:

Keywords

Alcohol • Oxidative stress • Protein damage • Neurodegeneration • Neural cells • Oxidatively damaged proteins

Introduction

Alcohol consumption is deeply ingrained in human culture and social practices. However, its widespread use is accompanied by a myriad of health consequences, ranging from liver damage to cognitive impairment. Among the detrimental effects of chronic alcohol consumption, neurobiological alterations hold significant importance due to their profound impact on cognitive function, behavior, and overall well-being. One of the mechanisms through which alcohol exerts its deleterious effects on the nervous system is by inducing oxidative stress, leading to the accumulation of oxidatively damaged proteins in neural cells and tissues. Oxidative stress occurs when there is an imbalance between the production of Reactive Oxygen Species (ROS) and the cell's ability to detoxify them or repair the resulting damage. Chronic alcohol consumption disrupts the delicate balance of redox homeostasis in the nervous system, leading to an overabundance of ROS. These ROS, including superoxide anion (O₂⁻), hydrogen peroxide (H₂O₂) and hydroxyl radical (OH), inflict damage on various cellular components, including lipids, nucleic acids and proteins.

Proteins are essential for the structure, function and regulation of cells and tissues. However, under conditions of oxidative stress, proteins are susceptible to damage through various mechanisms, including oxidation, nitration and carbonylation. Oxidatively damaged proteins undergo conformational changes that may impair their function and render them more prone to aggregation. Furthermore, damaged proteins may escape the quality control mechanisms of the cell, leading to their accumulation within neural cells and tissues. The accumulation of oxidatively damaged proteins has profound neurobiological consequences, contributing to neuronal dysfunction, synaptic impairment and ultimately neurodegeneration. Aggregated proteins can disrupt cellular processes by interfering with signaling pathways, impairing proteostasis and inducing cytotoxicity. In addition, protein aggregates can trigger inflammatory responses and activate cell death pathways, further exacerbating neuronal damage and loss [1].

Literature Review

Alcohol-induced oxidative stress represents a significant risk factor for the accumulation of oxidatively damaged proteins in neural cells and tissues. Understanding the mechanisms underlying this phenomenon is crucial for elucidating the pathophysiology of alcohol-related neurodegeneration. Moreover, targeting pathways involved in protein damage and aggregation may offer novel therapeutic strategies for mitigating the neurological consequences of alcohol abuse. Efforts to prevent and treat alcohol-related neurodegeneration should focus not only on reducing alcohol consumption but also on counteracting the detrimental effects of oxidative stress on protein homeostasis in the nervous system. Oxidative stress-induced protein damage encompasses a variety of chemical modifications, each with distinct consequences for protein structure and function. Oxidation of amino acid side chains, such as cysteine, methionine, and tyrosine, can lead to the formation of reactive intermediates, protein cross-linking, and altered protein-protein interactions. Nitration of tyrosine residues by Reactive Nitrogen Species (RNS), such as peroxynitrite (ONOO−), can result in changes to protein conformation and enzymatic activity. Carbonylation, a hallmark of protein oxidation, involves the addition of carbonyl groups to amino acid side chains, leading to protein dysfunction and susceptibility to degradation [2].

Cells possess intricate protein quality control mechanisms to maintain proteostasis and prevent the accumulation of damaged proteins. Chaperone proteins, such as Heat Shock Proteins (HSPs), assist in protein folding, refolding, and degradation, thereby minimizing the formation of protein aggregates. The Ubiquitin-Proteasome System (UPS) and Autophagy-Lysosomal Pathway (ALP) are responsible for the selective degradation of damaged or misfolded proteins. However, under conditions of chronic alcohol exposure and oxidative stress, these proteostatic mechanisms may become overwhelmed, leading to the accumulation of oxidatively damaged proteins and the formation of intracellular aggregates. The accumulation of oxidatively damaged proteins is implicated in the pathogenesis of various neurological disorders, including Alzheimer's Disease (AD), Parkinson's Disease (PD) and Amyotrophic Lateral Sclerosis (ALS). In these neurodegenerative conditions, aberrant protein aggregation is a common pathological feature, contributing to neuronal dysfunction and death. Alcohol-induced protein damage and aggregation may synergize with diseasespecific mechanisms, exacerbating neurodegeneration and accelerating disease progression. Moreover, the effects of alcohol on protein homeostasis may have implications for cognitive decline, mood disorders, and alcoholrelated brain damage [3].

Targeting protein damage and aggregation represents a promising therapeutic approach for mitigating the neurological consequences of alcohol abuse and related disorders. Strategies aimed at enhancing protein quality control mechanisms, such as upregulating chaperone expression or modulating proteasome and autophagy activity, could help prevent the accumulation of damaged proteins and alleviate neurotoxicity. Small molecule compounds that inhibit protein aggregation or promote protein degradation pathways may also hold therapeutic potential. Furthermore, lifestyle interventions, such as dietary supplementation with antioxidants and polyphenols, may attenuate oxidative stress and mitigate protein damage in the nervous system. The accumulation of oxidatively damaged proteins in neural cells and tissues represents a significant consequence of chronic alcohol consumption and oxidative stress. Understanding the mechanisms underlying protein damage and aggregation is crucial for elucidating the pathophysiology of alcohol-related neurodegeneration and developing targeted therapeutic interventions. Future research efforts should focus on identifying novel targets and strategies to preserve protein homeostasis and mitigate the neurological consequences of alcohol abuse. By addressing the molecular mechanisms underlying alcoholinduced protein damage, we may pave the way for more effective treatments and interventions to protect brain health and improve outcomes for individuals affected by alcohol-related neurodegeneration [4,5].

Discussion

Recent advances in the field have uncovered novel mechanisms underlying alcohol-induced protein damage and aggregation, opening new avenues for research and therapeutic development. Emerging evidence suggests that noncoding RNAs, such as microRNAs and long non-coding RNAs, play critical roles in regulating protein homeostasis and neuronal function. Dysregulation of these RNA-based pathways by alcohol and oxidative stress may contribute to protein aggregation and neurodegeneration. Investigating the crosstalk between RNA-mediated mechanisms and protein quality control pathways may reveal new therapeutic targets for combating alcohol-related neurotoxicity. Translating basic research findings into clinical applications represents a critical step towards addressing the neurological consequences of alcohol abuse. Preclinical studies using animal models of alcohol dependence and neurodegeneration have identified promising therapeutic candidates, including antioxidants, anti-inflammatory agents, and proteostasis modulators. However, translating these interventions to human populations presents numerous challenges, including drug efficacy, safety and patient adherence [6].

Conclusion

Clinical trials evaluating the efficacy of antioxidant supplements, such as vitamin E and N-acetylcysteine (NAC), in mitigating alcohol-related neurotoxicity have yielded mixed results. Future clinical studies should focus on identifying biomarkers of protein damage and aggregation that can serve as surrogate endpoints for assessing treatment efficacy. Moreover, personalized medicine approaches based on individual genetic and metabolic profiles may enhance the precision and effectiveness of therapeutic interventions for alcohol-related neurological disorders. Addressing the public health burden of alcohol-related neurodegeneration requires a multifaceted approach encompassing prevention, early intervention, and treatment strategies. Public health initiatives aimed at reducing alcohol consumption and promoting responsible drinking behaviors are essential for minimizing the risk of neurotoxicity and cognitive decline. Education campaigns targeting healthcare providers, policymakers, and the general public can raise awareness about the neurological consequences of alcohol abuse and the importance of early detection and intervention.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Rehm, Jurgen, Benjamin Taylor, Satya Mohapatra and Hyacinth Irving, et al. "Alcohol as a risk factor for liver cirrhosis: A systematic review and meta‐analysis." Drug and Alcohol Rev 29 (2010): 437-445.

   Google Scholar, Crossref, Indexed at

2. Anstey, Kaarin J., Holly A. Mack and Nicolas Cherbuin. "Alcohol consumption as a risk factor for dementia and cognitive decline: Meta-analysis of prospective studies." Am J Geriatr Psychiatry 17 (2009): 542-555.

   Google Scholar, Crossref, Indexed at

3. Ronksley, Paul E., Susan E. Brien, Barbara J. Turner and Kenneth J. Mukamal, et al. "Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis." Bmj 342 (2011): d671.

   Google Scholar, Crossref, Indexed at

4. Prakash, Samay and Wayne G. Carter. "The neuroprotective effects of cannabis-derived phytocannabinoids and resveratrol in Parkinson’s disease: A systematic literature review of pre-clinical studies." Brain Sci 11 (2021): 1573.

   Google Scholar, Crossref, Indexed at

5. Eckardt, Michael J., Sandra E. File, Gian Luigi Gessa and Kathleen A. Grant, et al. "Effects of moderate alcohol consumption on the central nervous system." Alcohol Clin Exp Res 22 (1998): 998-1040.

   Google Scholar, Crossref, Indexed at

6. Kovalevich, Jane and Dianne Langford. "Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology." Neuronal cell culture: methods and protocols (2013): 9-21.

   Google Scholar, Indexed at